Israeli-based company Kanabo is shaking up the medical cannabis industry by developing an ecosystem focused on improving the health of millions around the world. They are prioritizing the distribution of cannabis-derived products for medicinal use, as well as non-THC products for CBD consumers. They have invested heavily in R&D to create high-quality cannabis oil formulas, innovative vaporizers, and consumption solutions that don't involve smoking. These efforts are making medical cannabis more accessible and user-friendly for those who need it.
Kanabo's ticker is KNB
The company's shares trade on the LSE stock exchange
They are based in London, England
There are 11-50 employees working at Kanabo
It is https://www.kanabogroup.com/
Kanabo is in the Healthcare sector